e-learning
resources
ERJ
2012
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Interaction of matrix metalloproteinases with pulmonary pollutants
Dagouassat M., Lanone S., Boczkowski J.
Source:
Eur Respir J 2012; 39: 1021-1032
Journal Issue:
April
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Dagouassat M., Lanone S., Boczkowski J.. Interaction of matrix metalloproteinases with pulmonary pollutants. Eur Respir J 2012; 39: 1021-1032
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
IgG4 disease and the lung
Dyspnoea in a patient with Osler's disease
Aortic dilation, Marfan disease and aortic dissection: links with OSA and impact of treatment
Related content which might interest you:
Matrix metalloproteinases in COPD
Source: Eur Respir J 2011; 39: 197-209
Year: 2012
Matrix metalloproteinases in COPD
Source: Eur Respir J 2012; 39: 197-209
Year: 2012
Impact of acute exposure to tobacco smoke on gelatinases in the bronchoalveolar space
Source: Eur Respir J 2008; 32: 644-650
Year: 2008
Matrix metalloproteinases and their inhibitors in pulmonary hypertension},
Source: Eur Respir J 2012; 40: 766-782
Year: 2012
Regulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases expression in the bronchial secretions of asthmatics and COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 92s
Year: 2002
Matrix metalloproteinases in tuberculosis
Source: Eur Respir J 2011; 38: 456-464
Year: 2011
Matrix metalloproteinases and tissue inhibitor of metalloproteinase-1 in sarcoidosis and IPF
Source: Eur Respir J 2002; 20: 1220-1227
Year: 2002
Matrix metalloproteinases (MMPs) and angiogenesis in lung tissue remodeling in different variants of idiopathic interstitial pneumonia (IIP)
Source: Eur Respir J 2007; 30: Suppl. 51, 137s
Year: 2007
Determination of lung function changes, sputum neutrophilia and metalloproteinases (MMPs) activities in workers at risk of repeated accidental inhalations of chlorine
Source: Eur Respir J 2002; 20: Suppl. 38, 603s
Year: 2002
Expression of matrix metalloproteinases in pigs with hyperoxia-induced acute lung injury
Source: Eur Respir J 2001; 18: 827-837
Year: 2001
High MMP-9 activity characterises pleural tuberculosis correlating with granuloma formation
Source: Eur Respir J 2009; 33: 134-141
Year: 2009
Matrix metalloproteinases in pulmonary fibrosis
Source: Annual Congress 2013 –Regulation of lung inflammation and repair by proteolysis
Year: 2013
Expression of elastolytic matrix metalloproteinases in bleomycin-induced pulmonary fibrosis
Source: Eur Respir J 2002; 20: Suppl. 38, 228s
Year: 2002
Extracellular matrix components and regulators in the airway smooth muscle in asthma
Source: Eur Respir J 2008; 32: 61-69
Year: 2008
Smooth muscle cell matrix metalloproteinases in idiopathic pulmonary arterial hypertension
Source: Eur Respir J 2005; 25: 834-842
Year: 2005
Increased serum concentrations of tissue inhibitor of metalloproteinase-1 in COPD patients
Source: Eur Respir J 2005; 25: 885-890
Year: 2005
Gelatinase expression in pulmonary arteries during experimental pulmonary hypertension
Source: Eur Respir J 2001; 18: 838-845
Year: 2001
Blood levels of matrix metalloproteinases (MMPs) and tissue inhibitors of matrix matalloproteinases (TIMPs) as biomarkers of COPD.
Source: International Congress 2018 – Functional genomics and COPD: new challenges
Year: 2018
Matrix metalloproteinases in acute lung injury: mediators of injury and drivers of repair
Source: Eur Respir J 2011; 38: 959-970
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept